Atlas Trials

A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Clinical trial NCT00827372 · COMPLETED

Trial details

NCT number
NCT00827372
Sponsor
Kathy Miller
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphedema
Start date
2009-01-01
Primary completion
2010-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.